(Q38176203)

English

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates

scientific article published on January 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates (English)

1 reference

Europe PubMed Central

30 August 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Thomas HC

1

1 reference

Europe PubMed Central

30 August 2017

Scully LJ

2

1 reference

Europe PubMed Central

30 August 2017

Lever AM

3

1 reference

Europe PubMed Central

30 August 2017

Yap I

4

1 reference

Europe PubMed Central

30 August 2017

Pignatelli M

5

1 reference

Europe PubMed Central

30 August 2017

publication date

1 January 1987

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

30 August 2017

15 Suppl 1

1 reference

Europe PubMed Central

30 August 2017

S26-31

1 reference

Europe PubMed Central

30 August 2017

https://scigraph.springernature.com/pub.10.1007/bf01650108

0 references

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1007%2FBF01650108

21 January 2018

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

1 reference

https://api.crossref.org/works/10.1007%2FBF01650108

21 January 2018

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1007%2FBF01650108

21 January 2018

Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial

1 reference

https://api.crossref.org/works/10.1007%2FBF01650108

21 January 2018

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of sexual preference and chronic hepatitis B virus infection on T lymphocyte subsets, natural killer activity, and suppressor cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon production by peripheral lymphocytes in HBsAg-positive liver diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HLA system: its relevance to the pathogenesis of liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approaches to the treatment of hepatitis B virus and delta-related liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homology between HBV-DNA and a sequence regulating the interferon-induced antiviral system: possible mechanism of persistent infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Vidarabine on Chronic Hepatitis B Virus Infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon deficiency syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2439462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01650108

1 reference

Europe PubMed Central

30 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38176203&oldid=1745934031"